Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
The summary for the Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional): This funding opportunity seeks to support the Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program. The CPACHE Program develops and maintains comprehensive, long-term, and mutually beneficial partnerships between institutions serving underserved health disparity populations and underrepresented students (ISUPSs) and NCI-designated Cancer Centers (CCs). The program aims to achieve a more robust national cancer program and address challenges in cancer and cancer disparities research, education, and outreach, as well as their impact on underserved populations. The institutions in each partnership are expected to work collaboratively to 1) increase the cancer research and cancer research education capacity of the ISUPSs; 2) increase the number of students and investigators from underrepresented populations engaged in cancer research; 3) improve the effectiveness of CCs in developing and sustaining research programs focused on cancer health disparities and increase the number of investigators and students conducting cancer health disparities research, and 4) develop and implement cancer-related activities that benefit the surrounding underserved communities.
| Federal Grant Title: | Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Education Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PAR-22-249 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | January 6th, 2023 |
| Original Application Deadline: | January 6th, 2023 |
| Posted Date: | October 26th, 2022 |
| Creation Date: | October 26th, 2022 |
| Archive Date: | February 11th, 2023 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | $2,000,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
| Last Updated: | October 26th, 2022 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/pa-files/PAR-22-249.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Early-Stage Development of Informatics Technologies for Cancer Research and Management (U0...
- • Advanced Development of Informatics Technologies for Cancer Research and Management (U24 C...
- • Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Cli...
- • NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Tri...
- • NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Require...
- • Pilot Studies in Pancreatic Cancer
- • Cancer Prevention Research Small Grant Program
- • Molecular Targets for Nutrients in Prostate Cancer Prevention
- More Grants from the National Institutes of Health
- • Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiologi...
- • Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- • Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not ...
- • Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- • Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P5...
